<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006001.pub2" GROUP_ID="LIVER" ID="630405102114143690" MERGED_FROM="" MODIFIED="2008-11-11 11:04:44 +0100" MODIFIED_BY="Dimitrinka Nikolova" NOTES="&lt;p&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;/p&gt;&lt;p&gt;Old title: Endoscopic retrograde cholangiopancreatico-graphy with or without stenting in patients with pancreatico-biliary stricture confirmed or suspected to be malignant, prior to surgery&lt;/p&gt;" NOTES_MODIFIED="2008-11-11 11:02:32 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="01" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2008-11-11 10:56:48 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgery</TITLE>
<CONTACT>
<PERSON ID="72DF2A8182E26AA201650CEAAE599D5B" MODIFIED="2008-11-11 10:56:38 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Khalid</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Mumtaz</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>khalid.mumtaz@aku.edu</EMAIL_1>
<EMAIL_2>drkmumtaz@yahoo.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>Aga Khan University Hospital</ORGANISATION>
<ADDRESS_1>Stadium Road</ADDRESS_1>
<ADDRESS_2>P.O. Box 74800</ADDRESS_2>
<CITY>Karachi</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-11 10:56:33 +0100" MODIFIED_BY="[Empty name]">
<PERSON ID="72DF2A8182E26AA201650CEAAE599D5B" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Khalid</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Mumtaz</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>khalid.mumtaz@aku.edu</EMAIL_1>
<EMAIL_2>drkmumtaz@yahoo.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>Aga Khan University Hospital</ORGANISATION>
<ADDRESS_1>Stadium Road</ADDRESS_1>
<ADDRESS_2>P.O. Box 74800</ADDRESS_2>
<CITY>Karachi</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="574B138982E26AA20088EE03ACDAC91D" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Saeed</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hamid</LAST_NAME>
<SUFFIX>MD; FRCP</SUFFIX>
<POSITION>Professor</POSITION>
<EMAIL_1>saeed.hamid@aku.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Medicine</DEPARTMENT>
<ORGANISATION>Aga Khan University Hospital</ORGANISATION>
<ADDRESS_1>Stadium Road</ADDRESS_1>
<ADDRESS_2>P.O. Box 3500</ADDRESS_2>
<CITY>Karachi</CITY>
<ZIP>74800</ZIP>
<REGION>Sind</REGION>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<PHONE_1>+ 92 21 493-0051 ext: 4671</PHONE_1>
<PHONE_2>+ 92 21 493-0051 ext: 4672</PHONE_2>
<FAX_1>+ 92 21 493-4294</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="10FAFC5982E26AA200492FF1C907B210" MODIFIED="2008-11-11 10:56:33 +0100" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Wasim</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Jafri</LAST_NAME>
<SUFFIX>MD; FRCP</SUFFIX>
<POSITION>Professor</POSITION>
<EMAIL_1>wasim.jafri@aku.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Medicine</DEPARTMENT>
<ORGANISATION>The Aga Khan University Hospital</ORGANISATION>
<ADDRESS_1>Stadium Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Karachi</CITY>
<ZIP>74800</ZIP>
<REGION>Sind</REGION>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<PHONE_1>+92 214 930 051</PHONE_1>
<PHONE_2/>
<FAX_1>+92 214 934 294</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-11 10:55:55 +0100" MODIFIED_BY="Dimitrinka Nikolova" NOTES="&lt;p&gt;Minor update: 5/23/07&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 10/1/06&lt;/p&gt;" NOTES_MODIFIED="2008-11-11 10:55:55 +0100" NOTES_MODIFIED_BY="Dimitrinka Nikolova">
<UP_TO_DATE>
<DATE DAY="23" MONTH="5" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="10" YEAR="2006"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="9" MONTH="11" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="11" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-11 10:56:48 +0100" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>The Cochrane Hepato-Biliary Group, Copenhagen</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Aga Khan University Hospital, Department of Medicine, Karachi</NAME>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY>
<TITLE>No evidence to support or refute endoscopic retrograde cholangiopancreaticography (ERCP) with stenting in patients with malignant pancreaticobiliary diseases, awaiting surgery</TITLE>
<SUMMARY_BODY>
<P>Pancreatico-biliary malignancy includes cancers of pancreas, ampulla, duodenum, and cholangiocarcinoma. There is significant morbidity and mortality related to surgery in these patients. Studies have claimed the beneficial role of biliary decompression, which can be performed via endoscopic retrograde cholangiopancreaticography (ERCP) with stent insertion pre-surgically. The review found that pre-surgical biliary stenting via ERCP did not improve the morbidity and mortality in patients with pancreatico-biliary malignancy. Further evidence about its efficiency is needed. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Postoperative morbidity and mortality are high in patients undergoing pancreatico-duodenectomy for malignant pancreatico-biliary stricture. Different approaches have been tried to improve the outcomes, including pre-surgical biliary stenting with endoscopic retrograde cholangiopancreaticography (ERCP). </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the beneficial and harmful effects of biliary stenting via ERCP for pancreatico-biliary stricture confirmed or suspected to be malignant, prior to surgery. </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We identified trials through <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I> (October 2006), the <I>Cochrane Central Register of Controlled Trials </I>(<I>CENTRAL</I>) in <I>The Cochrane Library</I> (Issue 2, 2006), <I>MEDLINE</I> (1950 to October 2006), <I>EMBASE </I>(1980 to October 2006), and <I>Science Citation Index Expanded</I> (1945 to October 2006). We also searched the references in the published papers and wrote to stent producers.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials comparing ERCP with biliary stenting versus ERCP without biliary stenting for pancreatico-biliary malignancy prior to surgery. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two authors independently selected trials for inclusion and extracted data. The primary pre-surgical, post-surgical, and final outcome measures were mortality. The secondary outcomes were complications such as cholangitis, pancreatitis, bleeding, pancreatic fistula, intra-abdominal abscess, improvement in bilirubin, and quality of life. Dichotomous outcomes were reported as odds ratio (OR) with 95% confidence interval (CI) based on fixed- and random-effect models. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>We identified two randomised trials with 125 patients undergoing pancreatico-duodenectomy; 62 patients underwent ERCP with biliary stenting and 63 had ERCP without biliary stenting prior to surgery. Pre-surgical mortality was not significantly affected by stenting (OR 3.14, 95% CI 0.12 to 79.26), while there were significantly more complications in the stented group (OR 43.75, 95% CI 2.51 to 761.8). Stenting had no significant effect on the post-surgical mortality (OR 0.75, 95% CI 0.25 to 2.24). However, post-surgical complications were significantly less in the stented group (OR 0.45, 95% CI 0.22 to 0.91). Overall mortality (OR 0.81, 95% CI 0.17 to 3.89) and complications (OR 0.50, 95% CI 0.01 to 23.68) were not significantly different in the two groups.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>We could not find convincing evidence to support or refute endoscopic biliary stenting on the mortality in patients with pancreatico-biliary malignancy. Large randomised trials are needed to settle the question of pre-surgical biliary stenting.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<P>Biliary obstruction is a frequent presenting feature of pancreatico-biliary malignancy (<LINK REF="REF-Conio-2001" TYPE="REFERENCE">Conio 2001</LINK>). Corrective surgery is the therapy of choice, but the majority of patients with pancreatico-biliary malignancy are incurable at the time of diagnosis due to local or distant metastases (<LINK REF="REF-England-1996" TYPE="REFERENCE">England 1996</LINK>). About one third of the patients with pancreatico-biliary malignancy are amenable to surgical resection after detailed evaluation with trans-abdominal ultrasound, computerized tomographic scan, magnetic resonance cholangiopancreaticography (MRCP), and endoscopic retrograde cholangiopancreaticography (ERCP) (<LINK REF="REF-Burke-1998" TYPE="REFERENCE">Burke 1998</LINK>; <LINK REF="REF-Tsao-2000" TYPE="REFERENCE">Tsao 2000</LINK>; <LINK REF="REF-Nakeeb-2002" TYPE="REFERENCE">Nakeeb 2002</LINK>).</P>
<P>Surgical treatment is found to be the best available option for patients diagnosed at a stage where the tumour is confined to the biliary tract (<LINK REF="REF-Abu_x002d_Hamda-2004" TYPE="REFERENCE">Abu-Hamda 2004</LINK>). Until recently, a postoperative morbidity of 30% to 65% and a postoperative mortality of 5% to 20% have often been reported (<LINK REF="REF-Lai-1992" TYPE="REFERENCE">Lai 1992</LINK>; <LINK REF="REF-Povoski-1999" TYPE="REFERENCE">Povoski 1999</LINK>). Several authors have reported five year survival as high as 30% to 40% in the subset of patients who obtained negative histologic margins at operation (<LINK REF="REF-Sugiura-1994" TYPE="REFERENCE">Sugiura 1994</LINK>; <LINK REF="REF-Klempnauer-1997" TYPE="REFERENCE">Klempnauer 1997</LINK>; <LINK REF="REF-Neuhaus-1999" TYPE="REFERENCE">Neuhaus 1999</LINK>). There are two ways to approach patients who are fit for surgical treatment: direct surgical approach or pre-surgical biliary decompression. The latter can be achieved either per-cutaneously, via per-cutaneous transhepatic cholangiography, or endoscopically, via ERCP along with stent placement (<LINK REF="REF-Stain-1992" TYPE="REFERENCE">Stain 1992</LINK>; <LINK REF="REF-Chamberlain-2000" TYPE="REFERENCE">Chamberlain 2000</LINK>). In the latter case, a fibre optic scope is inserted through the mouth to where the bile duct has its outlet in the small intestine (duodenum). Through the scope injection of contrast can be performed so that x-ray pictures can be taken. Furthermore, stents can be inserted into the biliary tract via the ERCP scope.</P>
<P>Pre-surgical biliary drainage has been used in an attempt to reduce morbidity and mortality in these patients. There are multiple non-randomised studies addressing this question. They are often against the use of routine pre-surgical endoscopic or per-cutaneous stenting (<LINK REF="STD-Martignoni-2001" TYPE="STUDY">Martignoni 2001</LINK>; <LINK REF="STD-Sewnath-2001" TYPE="STUDY">Sewnath 2001</LINK>; <LINK REF="STD-Jagannath-2005" TYPE="STUDY">Jagannath 2005</LINK>). Several meta-analyses of observational studies have addressed this issue. Ali et al found that pre-surgical biliary drainage does not decrease morbidity and mortality (<LINK REF="STD-Aly-2001" TYPE="STUDY">Aly 2001</LINK>). Flamm et al reported more complications in pre-surgical biliary drainage patients (<LINK REF="REF-Flamm-2002" TYPE="REFERENCE">Flamm 2002</LINK>). Despite this evidence, a great deal of controversy exists in this area and many centres routinely continue to practice pre-surgical biliary decompression. We have been unable to identify systematic reviews or meta-analyses of randomised clinical trials on the issue. We decided to explore the utility of preoperative endoscopic biliary drainage in patients with pancreatico-biliary stricture confirmed or suspected to be malignant, prior to surgery, by examining all randomised trials in a Cochrane systematic review. We only included trials that compared ERCP with stenting versus ERCP without stenting. Clinical trials on non-endoscopic preoperative drainage will be considered in other systematic reviews.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To evaluate the beneficial and harmful effects of biliary stenting via ERCP for pancreatico-biliary stricture confirmed or suspected to be malignant, prior to surgery. </P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-11 10:59:28 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>We included all randomised clinical trials, which compared pre-surgical endoscopic biliary drainage with no pre-surgical drainage in patients awaiting surgical procedure for a pancreatico-biliary stricture confirmed or suspected to be malignant. We excluded historically controlled trials, cohort studies, and case series. We included trials from journal articles and abstracts in any language, irrespective of blinding and year of publication. </P>
<P>We were only able to identify two randomised trials. Therefore, as a post hoc decision we also decided to analyse the non-randomised studies that we identified. This decision was taken knowing that it may only be a select group of studies we were able to identify. Furthermore, we are also aware of the weak inferences one is able to draw based on the non-randomised design. In spite of the fact that our wish to include such non-randomised studies as a kind of 'quality control' on the results from the randomised trials, we stress the risky nature of such control.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>
<B>Patients included<BR/>
</B>All patients, with peri-ampullary carcinoma (head of pancreas, ampullary, or duodenal) or cholangiocarcinoma, found to have a pancreatico-biliary stricture that is confirmed or suspected to be malignant and which is amenable to surgical correction. </P>
<P>
<B>Patients excluded<BR/>
</B>(1) Those with metastatic pancreatico-biliary disease. <BR/>(2) Those not fit for surgical correction procedure, such as pancreatico-duodenectomy, etc. <BR/>(3) Patients undergoing per-cutaneous trans-hepatic stenting. <BR/>(4) Those in whom ERCP was not possible (eg, previous Billroth II operation). </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>ERCP with biliary stenting versus ERCP without biliary stenting. </P>
<P>Trial on non-endoscopic preoperative drainage will not be included in the present review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>
<B>Pre-surgical primary outcome <BR/>
</B>(1) Mortality. <BR/>
<B>
<BR/>Pre-surgical secondary outcomes <BR/>
</B>(1) Complication, such as <BR/>(i) cholangitis, <BR/>(ii) pancreatitis, and <BR/>(iii) bleeding. <BR/>(2) Duration between ERCP and stenting. <BR/>(3) Haemoglobin, serum albumin, and serum bilirubin concentrations. <BR/>(4) Quality of life. <BR/>
<B>
<BR/>Post-surgical primary outcome <BR/>
</B>(1) Mortality at maximal follow-up. <BR/>
<B>
<BR/>Post-surgical secondary outcomes <BR/>
</B>(1) Complications, such as <BR/>(i) wound infection, <BR/>(ii) intra-abdominal abscess, <BR/>(iii) pancreatic fistula, and <BR/>(iv) bleeding. <BR/>(2) Quality of life. <BR/>(3) Length of hospital stay. <BR/>
<B>
<BR/>Total outcomes <BR/>
</B>(1) Overall mortality. <BR/>(2) Overall complications. </P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-11 10:59:28 +0100" MODIFIED_BY="[Empty name]">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register </I>(October 2006),<I> </I>the <I>Cochrane Central Register of Controlled Trials </I>(<I>CENTRAL</I>) in <I>The Cochrane Library </I>(Issue 2, 2006)<I>, MEDLINE </I>(1950 to October 2006),<I> EMBASE</I> (1980 to October 2006),<I> </I>and<I> Science Citation Index Expanded </I>(1945 to October 2006) (<LINK REF="REF-Royle-2003" TYPE="REFERENCE">Royle 2003</LINK>)<I>. </I>The search strategies used are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>
<I>.<BR/>
</I>
<BR/>We identified further trials by reading the reference lists of the identified studies. We wrote to the principal authors of the relevant trials and enquired about additional trials they might know of. We could not find unpublished trials from pharmaceutical companies involved in the production of stents and ERCP accessories.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-11 10:57:09 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors (KM and SH) extracted the pre-specified characteristics of the included trials independently. We sought the opinion of the third author (WJ) in case of disagreement. We contacted the authors of the trials if the data were not reported sufficiently in the publication. We performed meta-analyses following the instructions given in the <I>Cochrane Handbook for Systematic Reviews of Intervention</I> (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>) and the <I>Cochrane Hepato-Biliary Group Module </I>(<LINK REF="REF-Gluud-2007" TYPE="REFERENCE">Gluud 2007</LINK>).</P>
<P>
<B>Selection and data-extraction<BR/>
</B>We retrieved full articles for assessment and applied independently the inclusion criteria to all potential studies. From each trial we extracted age, gender, symptoms, biochemical laboratory parameters, including serum bilirubin, transaminases, alkaline phosphatases; type of the tumour such as periampullary carcinoma (pancreatic head tumour, duodenal tumour, ampullary tumour), or cholangiocarcinoma involving intra-hepatic, peri-hilar or distal bile duct along with pathologic diagnosis. We recorded ERCP findings with specifications of the biliary stent used, alongside with complications arising during ERCP and stenting such as pancreatitis, cholangitis, and bleed; the mortality related to the surgical intervention in both groups; and retrieved the data of surgical outcome in patients from both the groups. We extracted the data for our outcome measures listed above.</P>
<P>Two of the authors analysed all the included randomised trials independently and solved eventual disagreements by discussion. We listed all included and excluded trials, the latter with the reasons for exclusion.</P>
<P>We extracted the details of methods of endoscopic biliary drainage and the success rates prior to surgical intervention. We recorded the surgical interventions for the pancreatico-biliary malignancy treatment.</P>
<P>
<B>Methodological quality<BR/>
</B>Methodological quality was defined as the confidence that the design and report of the randomised trial would restrict bias in the comparison of the intervention (<LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>). According to empirical evidence (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>), we assessed the methodological quality of the trials based on the generation of the allocation sequence, allocation concealment, and blinding. These quality components were classified as follows:</P>
<UL>
<LI>Generation of the allocation sequence: adequate (computer generated random numbers, table of random numbers, or similar); unclear (the trial was described as randomised, but the generation of the allocation sequence was not described); or inadequate (quasi-randomised studies, which we primarily intended to exclude, but which will be analysed together with non-randomised studies).</LI>
<LI>Allocation concealment: adequate (concealed up to the point of treatment by central randomisation, sealed envelopes, or similar); unclear (the allocation concealment was not described); or inadequate (open table of random numbers, or similar).</LI>
<LI>Blinding: Due to the nature of the interventions, blinding of the patient, surgeon, endoscopist, and care-giver is not practicable. However, all trials could have employed blinded outcome assessment, and if so, we registered it.</LI>
</UL>
<P>
<BR/>We also registered whether the investigators have performed a sample-size calculation and used an intention-to-treat analysis.</P>
<P>
<B>Statistical methods<BR/>
</B>We used Review Manager 4.2 (<LINK REF="REF-RevMan-2003" TYPE="REFERENCE">RevMan 2003</LINK>). We used the intention-to-treat principle when analysing the data, that is, patients with missing data were considered treatment failures. Binary outcomes were expressed as relative risks (RR) and continuous outcomes as weighted mean differences (WMD) both with 95% confidence intervals (CI). We estimated rare events (pre-surgical morbidity and mortality) by Peto odds ratio (<LINK REF="REF-Deeks-1998" TYPE="REFERENCE">Deeks 1998</LINK>). For all analyses, we employed both random-effects (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>) and fixed-effect (<LINK REF="REF-Demets-1987" TYPE="REFERENCE">Demets 1987</LINK>) models. We reported the fixed-effect results when there was no discrepancy between the two models (both showing a significant intervention effect and both showing no significant intervention effect). Discrepancy between the two methods occurs only when there is heterogeneity. Since the trials were small and of low methodological quality, we were unable to perform everything described in the protocol part of the review, like we could not estimated funnel plot asymmetry using regression analysis (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) to examine potential bias. We explored heterogeneity using chi-squared test and we measured the quantity of heterogeneity by I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). We will explore sources of heterogeneity in assessment of treatment response in meta-regression analyses and subgroup analyses if enough trials are identified. When the number of trials allow, we will perform the following subgroup analyses to determine the impact of trial characteristics:</P>
<UL>
<LI>Methodological quality: comparison of intervention effect in trials with adequate compared to trials with inadequate or unclear generation of the allocation sequence, allocation concealment, and blinding.</LI>
<LI>Publication status: comparison of the intervention effect in trials published as full papers compared to trials published as abstracts or letter.</LI>
<LI>Co-interventions: comparison of the intervention effect in trials without co-interventions compared to trials with co-interventions.</LI>
<LI>Funnel plot asymmetry: bias will be assessed by looking for funnel plot asymmetry. We will perform the Begg and Mazumdar (<LINK REF="REF-Begg-1994" TYPE="REFERENCE">Begg 1994</LINK>) adjusted rank correlation test and the Egger (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) regression asymmetry test for bias.</LI>
</UL>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-11 10:58:39 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-11-11 10:58:38 +0100" MODIFIED_BY="[Empty name]">
<P>In total, we identified 12 studies presented in 12 publications. <BR/> <BR/>
<B>Included trials<BR/>
</B>Two randomised trials fulfilled the inclusion criteria of this review. There were 125 patients randomised (<LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK>; <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK>). Both trials investigated patients with malignant pancreatico-biliary stricture in which pancreatico-duodenectomy was done; one group with 62 patients underwent endoscopic biliary drainage prior to surgery, and the other group with 63 patients had a direct pancreatico-duodenectomy. Both trials had similar entry criteria of generally good quality, making it highly likely that all or almost all patients did, in fact, have malignant pancreatico-biliary stricture. The diagnostic modalities used for finding malignant diseases included ultrasonography, computerized tomography scan of abdomen, and ERCP in both the groups of patients. The distribution of the diagnosis in the two groups did not differ significantly and is presented in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. </P>
<P>The main outcome measures of both trials were divided into following categories: pre-surgical outcomes and post-surgical outcomes (mortality and complications). There were 41 males and 21 females in the stent group, and 39 males and 24 females were in the control group, ie, ERCP without biliary stenting. The mean age of patients in the stented and the no stented (control) groups was 62.5 and 63 years, respectively. Mortality was the primary outcome in both the trials. Only <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> et al described the details of pre-surgical secondary outcome, such as cholangitis, pancreatitis, and bleeding. Stenting was successful in <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> et al in 37/43 patients; two patients after stent insertion refused surgery. Only 33/87 patients underwent resection of tumour; choledocho-enteric bypass was done in 25, and intra-hepatic biliary enteric bypass was performed in 19. The details of 10 patients who could not undergo tumour resection were not given. Endoscopic biliary prosthesis was inserted successfully in all patients in the other group (<LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK>). </P>
<P>Neither <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> nor <LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK> provided information on the length of hospital stay after surgery. <BR/>
<BR/>Quality of life was not addressed in any of the two trials, neither as pre-surgical outcome nor as post-surgical outcome. <B>
<BR/>
</B>
<BR/>
<B>Excluded studies<BR/>
</B>The 10 excluded studies are listed with the reasons for exclusion in Characteristics of excluded studies table. </P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>The two identified trials had high risk of bias. Both trials were described as randomised trials. In the <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> trial, the allocation concealment was performed by drawing of a consecutively numbered envelope. There was no description on how the allocation sequence was generated. In the <LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK> trial, the generation of allocation sequence and allocation concealment were not described. </P>
<P>The sample size was calculated by <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> only; 33/87 patients had resection of tumour and the trial was terminated as the analysis of available data showed that the estimated sample size was inadequate. In addition, the hospital mortality rates of the two groups were close and it was considered that inclusion of the remaining patients as planned would have added no further information. </P>
<P>None of the two trials used blinded outcome assessment. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-11 10:58:39 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Presurgical primary outcome </B>
</P>
<P>
<B>Mortality <BR/>
</B>Combining the results of the two randomised trials, 1/62 patients died in the stented group versus 0/63 patients in the no stented group (OR 3.14, 95% CI 0.12 to 79.3). This patient died due to bleeding after precut for placing the stent (<LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK>). </P>
<P>
<B>Presurgical secondary outcomes </B>
</P>
<P>
<B>Overall complications <BR/>
</B>We found a total of 14/62 patients with complications in the stented group versus 0/63 patients in the no stented group (OR 43.75, 95% CI 2.51 to 761.8). </P>
<P>
<B>
<I>Cholangitis</I>
</B> <BR/>Cholangitis was reported in 10/62 patients in the stented group versus 0/63 patients in the no stented group (OR 27.90, 95% CI 1.58 to 493.1). </P>
<P>
<B>
<I>Pancreatitis</I>
</B> <BR/>None of the patients was reported to develop pancreatitis. </P>
<P>
<B>
<I>Bleeding </I>
</B>
<BR/>Bleeding occurred in 1/62 patients in the stented group versus 0/63 patients in the no stented group (OR 3.14, 95% CI 0.12 to 79.26). This patient died of uncontrollable bleeding (<LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK>). </P>
<P>
<B>Duration between ERCP and stenting </B>
<BR/>The exact duration was not mentioned in any of the two trials, but it seems that stenting was performed during the index ERCP. </P>
<P>
<B>Haemoglobin, serum albumin, and serum bilirubin </B>
<BR/>There was no difference in the haemoglobin and serum albumin levels in the two trials. <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> reported number of patients with improvement of serum bilirubin in 25/43 patients in the stented group versus 0/44 patients in the no stented group (OR 122.68, 95% CI 7.09 to 2122.7). <LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK> did not mention the number of patients with improvement in bilirubin. <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> provided data for serum bilirubin concentration.</P>
<P>
<B>Quality of life </B>
<BR/>None of the two trials addressed the quality of life issues. </P>
<P>
<B>Post-surgical primary outcome </B>
</P>
<P>
<B>Mortality at maximal follow-up </B>
<BR/>A total of 6/62 patients in the stented group versus 8/63 patients in the no stented group died (OR 0.75, 95% CI 0.25 to 2.24). The inter-trial heterogeneity (I<SUP>2</SUP>) was 6.4%. </P>
<P>
<B>Post-surgical secondary outcomes </B>
</P>
<P>
<B>Overall complications</B>
<B> </B>
<BR/>Complications were seen in 19/62 patients in the stented group versus 32/63 patients in the no stented group (OR 0.45, 95% CI 0.22 to 0.91). <LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK> et al did not report each complication separately. </P>
<P>
<B>
<I>Wound infection </I>
</B>
<BR/>
<LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK> reported the post-surgical wound infection in 1/19 patients in the stented group versus 4/19 patients in the no stented group (OR 0.21, 95% CI 0.02 to 2.07). </P>
<P>
<B>
<I>Intra-abdominal abscess</I>
</B> <BR/>Intra-abdominal abscess was reported by <LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK> in 1/19 patients in the stented group versus 3/19 patients in the no stented group (OR 0.30, 95% CI 0.03 to 3.14).</P>
<P>
<B>
<I>Pancreatic fistula</I>
</B> <BR/>None of the two trials reported on pancreatic fistula. </P>
<P>
<B>
<I>Bleeding</I>
</B>
<B> </B>
<BR/>Bleeding occurred in 0/19 patients in the stented group versus 1/19 in patients in the no stented group (OR 0.32, 95% CI 0.01 to 8.26) (<LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK>). </P>
<P>
<B>Quality of life</B>
<BR/>Neither of the two trials addressed it. </P>
<P>
<B>Length of hospital stay </B>
<BR/>It could not be calculated due to missing data.<BR/>
<B>
<BR/>Final outcome</B>
</P>
<P>
<B>Overall mortality </B>
<BR/>There were 15/125 deaths (OR 0.81, 95% CI 0.17 to 3.89); seven in the stented group versus eight in the no stented group. The inter-trial heterogeneity (I<SUP>2</SUP>) was 24%.</P>
<P>
<B>All complications</B>
<BR/>There were 65/125 complications (OR 0.50, 95% CI 0.01 to 23.68, random-effects model) seen in the two groups; 33 in the stented group versus 32 in the no stented group. The inter-trial heterogeneity (I<SUP>2</SUP>) was 94.4%.</P>
<P>
<B>Subgroup analyses</B>
<BR/>None of the subgroups of patients grouped according to diagnosis were statistically significant (Comparison 06; <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). </P>
<P>
<B>Post-hoc analysis of observational studies <BR/>
</B>We also evaluated the observational studies identified during our searches. As only two small randomised trials were available for analysis, we performed a post-hoc analysis of eight non-randomised studies comparing ERCP with stenting to ERCP without stenting (control group) in pancreatico-biliary malignancy awaiting surgery (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). </P>
<P>Post-hoc analysis of eight non-randomised studies with 878 patients in the endoscopic stenting group and 635 patients in the ERCP without stenting group showed no pre-surgical mortality in either group, but complications were not reported adequately. There were no statistically significant differences in post-surgical mortality (OR 0.91, 95% CI 0.51 to 1.60) and complications (OR 1.02, 95% CI, 0.80 to 1.29) among the stented and the control groups. The total mortality was not different in the two groups, but there were more overall complications in the stented group. </P>
<P>
<I>Pre-surgical primary outcome</I>
<B> </B>
</P>
<P>Mortality <BR/>In a total of eight non-randomised studies, 1513 patients were enrolled and one peri-operative mortality was reported by <LINK REF="STD-Heslin-1998" TYPE="STUDY">Heslin 1998</LINK> in the stented group (OR 2.77, 95% CI 0.11 to 70.14). The death occurred in the ERCP with stenting group, though it was not related to the pre-surgically placed stent. </P>
<P>
<I>Pre-surgical secondary outcomes</I>
</P>
<P>Overall complications <BR/>
<LINK REF="STD-Jagannath-2005" TYPE="STUDY">Jagannath 2005</LINK> reported 5/74 cases of cholangitis and pancreatitis each (OR 11.16, 95% CI 0.61 to 205.6); 4/74 patients also developed post stenting bleed in the same study (OR 9.00, 95% CI 0.48 to 170.3). The remaining seven studies did not mention on these events. In none of the studies overall complications were discussed. <BR/>
<B>
<BR/>
</B>Improvement in serum bilirubin<B>
<I> </I>
</B>
<BR/>Two non-randomised studies reported number of patients with improvement of serum bilirubin, ie, 225/547 patients in ERCP with stenting group (OR 338, 95% CI 46.63 to 2450). The remaining six studies have not mentioned the number of patients with improvement of serum bilirubin. </P>
<P>Quality of life <BR/>None of the non-randomised study looked into the quality of life issues. </P>
<P>
<I>Post-surgical secondary outcomes</I>
<B>
<BR/> <BR/>
</B>Mortality at maximal follow-up <BR/>In eight non-randomised studies, there was no difference in mortality between the two groups (OR 0.91, 95% CI 0.51 to 1.60); 25/878 patients in ERCP with stenting group versus 25/635 patients in the ERCP without stenting group died. The inter-trial heterogeneity was negligible (I<SUP>2</SUP> 0%). </P>
<P>
<I>Post-surgical secondary outcomes </I>
</P>
<P>Overall complications<B>
<I> </I>
</B>
<BR/>In eight non-randomised studies, complications were equally divided in the two groups (OR 1.02, 95% CI 0.80 to 1.29); there were 312/878 complications in the ERCP with stenting group versus 208/632 in the ERCP without stenting group. </P>
<P>Wound infection<B> </B>
<BR/>In eight non-randomised studies, wound infections were reported in 139/1513 patients (OR 1.57, 95%CI 1.06 to 2.32); 88/878 in the ERCP with stenting group versus 51/635 in the ERCP without stenting group.<BR/> <BR/>Intra-abdominal abscess<B> </B>
<BR/>Intra-abdominal abscess developed in a total of 135/1513 patients (OR 1.01, 95%CI 0.68 to 1.50); 83/878 patients in the ERCP with stenting group versus 52/635 patients in the ERCP without stenting group. </P>
<P>Pancreatic fistula <BR/>There were five non-randomised studies that reported pancreatic fistula in 49/985 patients (OR 1.00, 95%CI 0.54 to 1.86); 29/518 in the ERCP with stenting group versus 20/440 in the ERCP without stenting group. </P>
<P>Bleeding <BR/>Four studies reported bleeding in 80/752 patients (OR 0.57, 95%CI 0.34 to 0.96); 43/459 in the ERCP with stenting group versus 37/293 in the ERCP without stenting group. </P>
<P>Quality of life <BR/>Not addressed by any of the non-randomised trials. </P>
<P>Length of hospital stay <BR/>Three non-randomised studies reported length of stay, but there was not any uniformity in it. </P>
<P>
<I>Final outcomes</I>
</P>
<P>Overall mortality <BR/>There was similar mortality in the two groups (OR 0.94, 95% CI 0.54 to 1.66); 26/878 in the ERCP with stenting group versus 25/635 in the ERCP without stenting group. </P>
<P>All complications <BR/>There were 534/1513 complications seen in the two groups (OR 1.15, 95% CI 0.90 to 1.46); 326/878 in the stent group versus 208/635 in the ERCP without stenting group. </P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-11 11:00:11 +0100" MODIFIED_BY="[Empty name]">
<P>We found that ERCP with stenting has no significant harmful or beneficial effect on post-surgical mortality. There are too limited numbers of randomised trials with too sparse data to answer this question.</P>
<P>There has been a significant evolution in biliary drainage procedures over the last three decades in order to improve morbidity and mortality in patients with biliary obstruction awaiting corrective surgery. Earlier attempts at biliary drainage mainly related to the per-cutaneous route. The concept of biliary drainage in this context was proposed in 1970s, when <LINK REF="REF-Takada-1976" TYPE="REFERENCE">Takada 1976</LINK> and colleagues in a non-randomised study found that mortality fell from 28% to 8% when percutaneous biliary drainage was performed in patients with malignant jaundice before a surgical procedure. Further non-randomised studies by Nakayam and <LINK REF="REF-Gobien-1984" TYPE="REFERENCE">Gobien 1984</LINK> also found pre-surgery percutaneous biliary drainage to be useful. In 1980s, <LINK REF="REF-Denning-1981" TYPE="REFERENCE">Denning 1981</LINK> and <LINK REF="REF-Grundy-1984" TYPE="REFERENCE">Grundy 1984</LINK> again demonstrated effectiveness of percutaneous biliary drainage in non-randomised cohort studies (<LINK REF="REF-Denning-1981" TYPE="REFERENCE">Denning 1981</LINK>; <LINK REF="REF-Grundy-1984" TYPE="REFERENCE">Grundy 1984</LINK>). In order to confirm this finding, <LINK REF="REF-Hatfield-1982" TYPE="REFERENCE">Hatfield 1982</LINK>, <LINK REF="REF-McPherson-1984" TYPE="REFERENCE">McPherson 1984</LINK>, and <LINK REF="REF-Pitt-1985" TYPE="REFERENCE">Pitt 1985</LINK> conducted randomised trials and showed that, in fact, mortality and morbidity were higher in percutaneous biliary drainage patients as compared to those who went to surgery directly.</P>
<P>In the late 1980s, the trend changed towards firstly internal percutaneous drainage and then towards endoscopic drainage. Internal percutaneous drainage had been reported to have complications of its own and, therefore, could not gain support (<LINK REF="REF-Smith-1985" TYPE="REFERENCE">Smith 1985</LINK>). On the other hand, many non-randomised studies and their meta-analyses were performed to determine the role of endoscopic biliary drainage. However, the majority of these studies could not demonstrate any reduction in morbidity and mortality in patients with malignant jaundice awaiting surgery.</P>
<P>We found only two randomised trials looking at the issue of pre-surgical endoscopic biliary stenting compared with no stenting in patients with pancreatico-biliary malignancy awaiting surgery. Both trials were high-bias risk trials with poor methodology because of the unclear generation of randomisation sequence and lack of blinded outcome assessment and the unclear allocation concealment procedure in one of them. Pre-surgical mortality was reported in one patient related to ERCP after precut papillotomy prior to stent placement. The patient died due to exsanguinating bleeding. There were also a significant number of patients who developed cholangitis after ERCP (<LINK REF="STD-Lai-1994" TYPE="STUDY">Lai 1994</LINK>).</P>
<P>The two randomised trials show variable results when they are analysed separately. For example, in the study by <LINK REF="STD-Lygidakis-1987" TYPE="STUDY">Lygidakis 1987</LINK>, 38 patients were assigned to undergo pancreatico-duodenectomy; 19 with prior endoscopic stent placement and 19 without stent placement. There were 16% complications and no deaths in the stented group as compared to 74% complications and 2 deaths in the no stented group. This is the only study that demonstrated a highly significant reduction in post-surgical morbidity or mortality between the groups with or without pre-surgical stent placement. On the other hand, the study by <LINK REF="REF-Lai-1992" TYPE="REFERENCE">Lai 1992</LINK> did not report any difference in post-surgical morbidity and mortality between the groups with or without stent placement. Only 23 patients underwent pancreatico-duodenectomy in this trial and, though it is not possible to extract the data pertaining to complications, mortality was similar in the two groups.</P>
<P>When we analysed the results of two trials together, we found that the rate of overall post-surgical mortality was not significantly different in the groups that did or did not have pre-surgical stent placement, but that there was weak evidence of benefit of pre-surgical stenting in preventing post-surgical complications.</P>
<P>The results of non-randomised studies are consistent with the findings of the two small randomised trials in showing no significant benefit or harm related to prior endoscopic biliary drainage in patients with pancreatico-biliary malignancy awaiting surgery (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>What happens to the patients intra-operatively after stent placement? There are different kinds of intra-operative problems when endoprosthesis (stent) is placed before surgery; there is inflammatory response to stent which causes difficulty in dissection, increased blood loss, and anastomosis difficulty in fibrotic ducts. In a retrospective study of 212 patients, <LINK REF="STD-Hodul-2003" TYPE="STUDY">Hodul 2003</LINK> reported longer operative time (mean 6.8 hours versus 6.5 hours) and increased intra-operative blood loss (mean: 1207 ml versus 1122 ml). Contrary to this, <LINK REF="REF-Peskova-2004" TYPE="REFERENCE">Peskova 2004</LINK> in their 304 patients, did not find any significant difference in the surgical procedure duration and the peri-operative blood loss. The effects of stents on bile duct morphology and consequent technical problems encountered at surgery were studied in 31 consecutive patients undergoing pancreatico-duodenectomies by <LINK REF="REF-Wagholikar-2003" TYPE="REFERENCE">Wagholikar 2003</LINK>. Stented ducts were significantly narrower (luminal diameter 9 [7 to 12] mm compared to 17.5 [8 to 23] mm; P = 0.0001) and had thicker walls (2.3 [1.3 to 3.5] mm compared to 1.85 [0.8 to 2.2] mm; P = 0.004) compared to non-stented ones. On microscopy, stented ducts had advanced grades of sub-mucosal gland hypertrophy, fibrosis, and inflammatory cell infiltrate. The author has reported difficulty in bile duct dissection which was encountered more often in patients who had been stented than in those without stents, though the difference was not statistically significant.</P>
<P>Similarly <LINK REF="REF-Karsten-1992" TYPE="REFERENCE">Karsten 1992</LINK> in their 30 patients studied the morphological changes of the extra-hepatic biliary tract during obstruction and the effects of biliary decompression by means of an endoprosthesis on the bile duct wall by light microscopy and scanning electron microscopy. They found that their patients with endoprosthesis were having severe inflammatory changes with considerable fibrosis and ulcerative lesions, resulting in markedly thickened ducts with lumina approximating the diameter of the stent. On the other hand, the patients with obstructed ducts without endoprosthesis had mild inflammation, a moderate degree of fibrosis, and local epithelial disintegration. Though the above evidence is not conclusive, it appears that there is likelihood that the local inflammation due to stent can cause operative problems, such as difficult dissection, increased per-operative bleeding and thickening of the bile duct with fibrosis causing anastomosis problems.</P>
<P>There is a need for a large randomised trial with good collaboration between gastroenterologists and surgeons to settle this very important issue of presurgical drainage in patients with pancreatic-biliary malignancy. Furthermore, whenever such trials are designed, they must address the issue of surgical problems with or without stenting.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>On the basis of the only two randomised high-bias risk trials included in this systematic review, pre-surgical endoscopic biliary drainage in patients with malignant pancreaticobiliary stricture awaiting surgery cannot be supported or refuted. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Further properly designed randomised trials with sufficient statistical power, adequate generation of the allocation sequence and allocation concealment, and adequate blinding of outcome assessment should be initiated to evaluate the use of pre-surgical endoscopic biliary drainage in patients with malignant pancreatico-biliary stricture awaiting surgery. This clinical practice of endoscopic biliary drainage must be avoided until result from such trials can guide future practice. Furthermore, future trials should also provide data regarding additional, clinically relevant aspects, such as duration of hospital stay, frequency of post ERCP cholangitis, pancreatitis, individual post-surgical complications, and problems during the following surgery. None of the trials has dealt with the important issue of quality of life so it has to be incorporated in the future trials also. Future trials ought to be reported following the CONSORT Guidelines (http://www.consort-statement.org).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We thank Christian Gluud, Dimitrinka Nikolova, and the other team members of The Cochrane Hepato-Biliary Group, for help during the development of this review. We also thank our surgery colleague, Tabish Chawla, for helping us with surgical issues of this review. </P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known. </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Khalid Mumtaz drafted the protocol and performed the literature searches, data extraction, and drafted the final review. <BR/>Saeed Hamid revised the protocol and helped in literature searches, reviewed the trials, extracted data, and helped in writing the final review. <BR/>Wasim Jafri helped in reviewing the studies and revising the final protocol and review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Lai-1994" NAME="Lai 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lai EC, Mok FP, Fan ST, Lo CM, Chu KM, Liu CL, et al</AU>
<TI>Preoperative endoscopic drainage for malignant obstructive jaundice</TI>
<SO>British Journal of Surgery</SO>
<YR>1994</YR>
<VL>81</VL>
<NO>8</NO>
<PG>1195-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7741850"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lygidakis-1987" NAME="Lygidakis 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lygidakis NJ, van der Heyde MN, Lubbers MJ</AU>
<TI>Evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma</TI>
<SO>Acta Chirurgica Scandinavica</SO>
<YR>1987</YR>
<VL>153</VL>
<NO>11-12</NO>
<PG>665-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3434110"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Aly-2001" NAME="Aly 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aly EA, Johnson CD</AU>
<TI>Preoperative biliary drainage before resection in obstructive jaundice</TI>
<SO>Digestive Surgery</SO>
<YR>2001</YR>
<VL>18</VL>
<PG>84-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11351150"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heslin-1998" NAME="Heslin 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heslin MJ, Brooks AD, Hochwald SN, Harrison LE, Blumgart LH, Brennan MF</AU>
<TI>A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy</TI>
<SO>Archives of Surgery</SO>
<YR>1998</YR>
<VL>133</VL>
<NO>2</NO>
<PG>149-54</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="94484726"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hodul-2003" NAME="Hodul 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hodul P, Creech S, Pickleman J, Aranha GV</AU>
<TI>The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy</TI>
<SO>American Journal of Surgery</SO>
<YR>2003</YR>
<VL>186</VL>
<NO>5</NO>
<PG>420-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14599600"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jagannath-2005" NAME="Jagannath 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jagannath P, Dhir V, Shrikhande S, Shah RC, Mullerpatan P, Mohandas KM</AU>
<TI>Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy</TI>
<SO>British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<NO>3</NO>
<PG>356-61</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15672425"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marcus-1998" NAME="Marcus 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marcus SG, Dobryansky M, Shamamian P, Cohen H, Gouge TH, Pachter HL, et al</AU>
<TI>Endoscopic biliary drainage before pancreaticoduodenectomy for periampullary malignancies</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>2</NO>
<PG>125-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9563924"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martignoni-2001" NAME="Martignoni 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martignoni ME, Wagner M, Krahenbuhl L, Redaelli CA, Friess H, Buchler MW</AU>
<TI>Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy</TI>
<SO>American Journal of Surgery</SO>
<YR>2001</YR>
<VL>181</VL>
<NO>1</NO>
<PG>52-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11248177"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pisters-2001" NAME="Pisters 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, et al</AU>
<TI>Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients</TI>
<SO>Annals of Surgery</SO>
<YR>2001</YR>
<VL>234</VL>
<NO>1</NO>
<PG>47-55</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11420482"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sewnath-2001" NAME="Sewnath 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sewnath ME, Birjmohun RS, Rauws EA, Huibregtse K, Obertop H, Gouma DJ</AU>
<TI>The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy</TI>
<SO>Journal of American College of Surgeons</SO>
<YR>2001</YR>
<VL>192</VL>
<NO>6</NO>
<PG>726-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11400966"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sohn-2000" NAME="Sohn 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sohn TA, Yeo CJ, Cameron JL, Pitt HA, Lillemoe KD</AU>
<TI>Do pancreatic biliary stents increase postpancreaticoduodenectomy complications?</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>3</NO>
<PG>258-68</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10769088"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Srivastava-2001" NAME="Srivastava 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Srivastava S, Sikora SS, Kumar A, Saxena R, Kapoor VK</AU>
<TI>Outcome following pancreaticoduodenectomy in patients undergoing preoperative biliary drainage</TI>
<SO>Digestive Surgery</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>5</NO>
<PG>381-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11721113"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abu_x002d_Hamda-2004" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Abu-Hamda 2004" TYPE="JOURNAL_ARTICLE">
<AU>Abu-Hamda EM, Baron TH</AU>
<TI>Endoscopic management of cholangiocarcinoma</TI>
<SO>Seminars in Liver Diseases</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>2</NO>
<PG>165-75</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15192789"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Aly-2001" NAME="Aly 2001" TYPE="JOURNAL_ARTICLE">
<AU>Aly EA, Johnson CD</AU>
<TI>Preoperative biliary drainage before resection in obstructive jaundice</TI>
<SO>Digestive Surgery</SO>
<YR>2001</YR>
<VL>18</VL>
<PG>84-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11351150"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Begg-1994" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Begg 1994" TYPE="JOURNAL_ARTICLE">
<AU>Begg CB, Mazumdar M</AU>
<TI>Operating characteristics of a rank correlation test for publication bias</TI>
<SO>Biometrics</SO>
<YR>1994</YR>
<VL>50</VL>
<NO>4</NO>
<PG>1088-101</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burke-1998" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Burke 1998" TYPE="JOURNAL_ARTICLE">
<AU>Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH</AU>
<TI>Hilar cholagiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clincal staging system</TI>
<SO>Annals of Surgery</SO>
<YR>1998</YR>
<VL>228</VL>
<PG>385-94</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9742921"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chamberlain-2000" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Chamberlain 2000" TYPE="JOURNAL_ARTICLE">
<AU>Chamberlain RS, Blumgart LH</AU>
<TI>Hilar cholangiocarcinoma: a review and commentary</TI>
<SO>Annals of Surgical Oncology</SO>
<YR>2000</YR>
<VL>7</VL>
<PG>55-66</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10674450"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Conio-2001" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Conio 2001" TYPE="JOURNAL_ARTICLE">
<AU>Conio M, Demarquay J, De Luca L, Marchi S, Dumas R</AU>
<TI>Endoscopic treatment of pancreatic-biliary malignancies</TI>
<SO>Critical Reviews in Oncology/Hematology</SO>
<YR>2001</YR>
<VL>37</VL>
<PG>127-35</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11166586"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deeks-1998" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Deeks 1998" TYPE="CONFERENCE_PROC">
<AU>Deeks JJ, Bradburn MJ, Localio R, Berlin J</AU>
<TI>Much ado about nothing: meta-analysis for rare events [abstract]</TI>
<SO>Proceedings of 2nd symposium on systematic reviews: beyond the basics. 6th International Cochrane Colloquium</SO>
<YR>1998</YR>
<PG>50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Demets-1987" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Demets 1987" TYPE="JOURNAL_ARTICLE">
<AU>Demets DL</AU>
<TI>Methods for combining randomized clinical trials: strengths and limitations</TI>
<SO>Statistics in Medicine</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>3</NO>
<PG>341-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Denning-1981" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Denning 1981" TYPE="JOURNAL_ARTICLE">
<AU>Denning DA, Ellison EC, Carey LC</AU>
<TI>Preoperative percutaneous transhepatic biliary decompression lowers operative morbidity in patients with obstructive jaundice</TI>
<SO>American Journal of Surgery</SO>
<YR>1981</YR>
<VL>141</VL>
<NO>1</NO>
<PG>61-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<PG>177-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Smith GD, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple graphical test</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-England-1996" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="England 1996" TYPE="JOURNAL_ARTICLE">
<AU>England RE, Martin DF</AU>
<TI>Endoscopic and percutaneous intervention in malignant obstructive jaundice</TI>
<SO>Cardiovascular Interventional Radiology</SO>
<YR>1996</YR>
<VL>19</VL>
<PG>381-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8994702"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Flamm-2002" MODIFIED="2008-11-11 11:02:32 +0100" MODIFIED_BY="[Empty name]" NAME="Flamm 2002" TYPE="JOURNAL_ARTICLE">
<AU>Flamm CR, Mark DH, Aronson N</AU>
<TI>Evidence based assessment of ERCP approaches to managing pancreaticobiliary malignancies</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2002</YR>
<VL>56</VL>
<NO>6</NO>
<PG>218-25</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12447271"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2007" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Gluud 2007" NOTES="&lt;p&gt;Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, Fingerhut A, Gluud LL, Gurusamy K, Khan S, Koretz R, Liu JP, Myers R, Pagliaro L, Simonetti R, Sutton R. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.&lt;/p&gt;" NOTES_MODIFIED="2008-11-11 10:58:40 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al</AU>
<TI>Cochrane Hepato-Biliary Group</TI>
<SO>About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gobien-1984" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Gobien 1984" TYPE="JOURNAL_ARTICLE">
<AU>Gobien RP, Stanley JH, Soucek CD, Anderson MC, Vujic I, Gobien BS</AU>
<TI>Routine preoperative biliary drainage: effect on management of obstructive jaundice</TI>
<SO>Radiology</SO>
<YR>1984</YR>
<VL>152</VL>
<NO>2</NO>
<PG>53-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grundy-1984" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Grundy 1984" TYPE="JOURNAL_ARTICLE">
<AU>Grundy SR, Strodel WE, Knoll JA, Eckhauser FE</AU>
<TI>Efficacy of preoperatiev biliary tract decompression in patietns with obstructive jaundice</TI>
<SO>Archives of Surgery</SO>
<YR>1984</YR>
<VL>119</VL>
<PG>703-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hatfield-1982" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Hatfield 1982" TYPE="JOURNAL_ARTICLE">
<AU>Hatfield AR, Tobias R, Terblanche J, Girdwood AH, Fataar S, Harries-Jones R</AU>
<TI>Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial</TI>
<SO>Lancet</SO>
<YR>1982</YR>
<VL>2</VL>
<NO>8304</NO>
<PG>896-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2006" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2006" NOTES="&lt;p&gt;Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;" NOTES_MODIFIED="2008-11-11 10:58:40 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]</TI>
<SO>The Cochrane Library, Issue 4, 2006</SO>
<PB>John Wiley &amp; sons, Ltd</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hodul-2003" NAME="Hodul 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hodul P, Creech S, Pickleman J, Aranha GV</AU>
<TI>The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy</TI>
<SO>American Journal of Surgery</SO>
<YR>2003</YR>
<VL>186</VL>
<NO>5</NO>
<PG>420-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="PMID: 14599600"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jagannath-2005" NAME="Jagannath 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jagannath P, Dhir V, Shrikhande S, Shah RC, Mullerpatan P, Mohandas KM</AU>
<TI>Effect of preoperative biliary stenting on immediate outcome after pancreaticoduodenectomy</TI>
<SO>British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<PG>356-61</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15672425"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Karsten-1992" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Karsten 1992" TYPE="JOURNAL_ARTICLE">
<AU>Karsten TM, Coene PP, van Gulik TM, Bosma A, van Marle J, James J, et al</AU>
<TI>Morphologic changes of extrahepatic bile ducts during obstruction and subsequent decompression by endoprosthesis</TI>
<SO>Surgery</SO>
<YR>1992</YR>
<VL>111</VL>
<NO>5</NO>
<PG>562-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1598676"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klempnauer-1997" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Klempnauer 1997" TYPE="JOURNAL_ARTICLE">
<AU>Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R</AU>
<TI>Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1997</YR>
<VL>15</VL>
<PG>947-54</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9060532"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lai-1992" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Lai 1992" TYPE="JOURNAL_ARTICLE">
<AU>Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM, et al</AU>
<TI>Surgery for malignant obstructive jaundice: analysis of mortality</TI>
<SO>Surgery</SO>
<YR>1992</YR>
<VL>112</VL>
<PG>891-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1440241"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Martignoni-2001" NAME="Martignoni 2001" TYPE="JOURNAL_ARTICLE">
<AU>Martignoni ME, Wagner M, Krahenbuhl L, Redaelli CA, Friess H, Buchler MW</AU>
<TI>Effects of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy</TI>
<SO>American Journal of Surgery</SO>
<YR>2001</YR>
<VL>181</VL>
<PG>52-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11248177"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McPherson-1984" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="McPherson 1984" TYPE="JOURNAL_ARTICLE">
<AU>McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB, Allison DJ, Blumgart LH</AU>
<TI>Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial</TI>
<SO>British Journal of Surgery</SO>
<YR>1984</YR>
<VL>71</VL>
<NO>5</NO>
<PG>371-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nakeeb-2002" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Nakeeb 2002" TYPE="JOURNAL_ARTICLE">
<AU>Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Pitt HA, et al</AU>
<TI>Improved survival in resected malignancies</TI>
<SO>Surgery</SO>
<YR>2002</YR>
<VL>4</VL>
<PG>555-63</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12407338"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neuhaus-1999" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Neuhaus 1999" TYPE="JOURNAL_ARTICLE">
<AU>Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al</AU>
<TI>Extended resection for hilar cholangiocarcinoma</TI>
<SO>Annals of Surgery</SO>
<YR>1999</YR>
<VL>230</VL>
<PG>808-18</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10615936"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Peskova-2004" MODIFIED="2008-11-11 11:00:11 +0100" MODIFIED_BY="[Empty name]" NAME="Peskova 2004" TYPE="JOURNAL_ARTICLE">
<AU>Peskova M, Gurlich R</AU>
<TI>Preoperative biliary drainage in the pancreatic head carcinoma</TI>
<SO>Rozhledy v Chirurgii</SO>
<YR>2004</YR>
<VL>83</VL>
<NO>12</NO>
<PG>624-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15736394"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pitt-1985" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Pitt 1985" TYPE="JOURNAL_ARTICLE">
<AU>Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS, Longmire WP Jr</AU>
<TI>Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?</TI>
<SO>Annals of Surgery</SO>
<YR>1985</YR>
<VL>201</VL>
<NO>5</NO>
<PG>545-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Povoski-1999" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Povoski 1999" TYPE="JOURNAL_ARTICLE">
<AU>Povoski SP, Karpeh MS, Conlon KC, Blumgart LH, Brennan MF</AU>
<TI>Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy</TI>
<SO>Annals of Surgery</SO>
<YR>1999</YR>
<VL>230</VL>
<NO>2</NO>
<PG>131-42</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10450725"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2003" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2003</YR>
<EN>4.2 for Windows</EN>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royle-2003" MODIFIED="2008-11-11 10:59:29 +0100" MODIFIED_BY="[Empty name]" NAME="Royle 2003" NOTES="&lt;p&gt;'International Journal of Technology Assessment in Health Care' 2003;19:4:591-603 with a title 'Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches' by Royle P et al.&lt;/p&gt;" NOTES_MODIFIED="2008-11-11 10:59:29 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Royle P, Milne R</AU>
<TI>Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>591-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sewnath-2001" NAME="Sewnath 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sewnath ME, Birjmohun RS, Rauws EA, Huibregtse K, Obertop H, Gouma DJ</AU>
<TI>The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy</TI>
<SO>Journal of American College of Surgery</SO>
<YR>2001</YR>
<VL>192</VL>
<NO>6</NO>
<PG>726-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11400966"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Smith-1985" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 1985" TYPE="JOURNAL_ARTICLE">
<AU>Smith RC, Pooley M, George CR, Faithful GR</AU>
<TI>Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function</TI>
<SO>Surgery</SO>
<YR>1985</YR>
<VL>97</VL>
<NO>6</NO>
<PG>641-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stain-1992" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Stain 1992" TYPE="JOURNAL_ARTICLE">
<AU>Stain SC, Baer HU, Dennison AR, Blumgart LH</AU>
<TI>Current management of hilar cholangiocarcinoma</TI>
<SO>Surgery, Gynecology &amp; Obstetrics</SO>
<YR>1992</YR>
<VL>175</VL>
<PG>579-88</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1280374"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sugiura-1994" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Sugiura 1994" TYPE="JOURNAL_ARTICLE">
<AU>Sugiura Y, Nakamura S, Iida S, Hosoda Y, Ikeuchi S, Mori S, et al</AU>
<TI>Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group</TI>
<SO>Surgery</SO>
<YR>1994</YR>
<VL>115</VL>
<PG>445-51</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8165536"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Takada-1976" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Takada 1976" TYPE="JOURNAL_ARTICLE">
<AU>Takada T, Hanyu F, Kobayashi S, Uchida Y</AU>
<TI>Percutaneous transhepatic cholangial drainage: direct approach under fluoroscopic control</TI>
<SO>Journal of Surgical Oncology</SO>
<YR>1976</YR>
<VL>8</VL>
<NO>1</NO>
<PG>83-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tsao-2000" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Tsao 2000" TYPE="JOURNAL_ARTICLE">
<AU>Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, et al</AU>
<TI>Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience</TI>
<SO>Annals of Surgery</SO>
<YR>2000</YR>
<VL>232</VL>
<PG>166-74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10903592"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wagholikar-2003" MODIFIED="2008-11-11 11:00:11 +0100" MODIFIED_BY="[Empty name]" NAME="Wagholikar 2003" TYPE="JOURNAL_ARTICLE">
<AU>Wagholikar GD, Sikora SS, Pandey R, Prasad KK, Kumar A, Saxena R, et al</AU>
<TI>Morphological changes in bile ducts following preoperative biliary stenting</TI>
<SO>Indian Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>5</NO>
<PG>166-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14658530"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Lai-1994">
<CHAR_METHODS>
<P>Randomised clinical trial. </P>
<P>Generation of the allocation sequence: unclear, not reported. </P>
<P>Allocation concealment: adequate, by drawing of consecutively numbered envelopes, that contained assigned treatment: either early surgery or a trial of pre-surgical drainage before definitive surgery. </P>
<P>Blinding: not performed. </P>
<P>Follow-up: no. </P>
<P>Intention-to-treat: no.</P>
<P>Sample size calculation: yes. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: Hong Kong. </P>
<P>Number of participants randomised: 87; 59 males and 28 females, mean age was 66 years. </P>
<P>Inclusion criteria: <BR/>Patients with malignant obstructive jaundice due to carcinoma of pancreas (41), ampullary carcinoma (5), gall bladder carcinoma (7), common bile duct carcinoma (16), intrahepatic cholangiocarcinoma (5), metastatic tumor (3). </P>
<P>Exclusion criteria: <BR/>37 patients were excluded during trial due to: refusal for surgery (8), high operative risk (11), disseminated disease (3), prior biliary drainage before referral (9), bleeding peptic ulcer (2), biliary sepsis (3), and previous gastrectomy (1). </P>
<P>The following investigations were performed for diagnosing cancer in all the participants: ultrasound of abdomen, computerised tomography scan of abdomen, and ERCP.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Participants were divided into two groups: </P>
<P>Group 1: underwent ERCP with stenting (n = 43) prior to surgery.</P>
<P>Group 2: underwent ERCP without stenting (n = 44) prior to surgery. </P>
<P>ERCP was performed with a side view duodenoscope (Olympus JF-IT20 or TJF-10), under local pharyngeal anaesthesia supplemented by intravenous diazepam as per need. A straight endoprosthesis of appropriate length and largest possible size was inserted in patients randomised to pre-surgical stenting. <BR/>When stent insertion was successful, drainage was performed for 2 weeks. If stenting failed, then the patient was subjected to early surgery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pre-surgical outcome measures: <BR/>Complications such as cholangitis and bleed; effective biliary decompression. </P>
<P>Post-surgical outcome measures: <BR/>Complications and mortality.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Drop outs or withdrawals: 7 patients could not be stented, 2 patients successfully stented refused surgery after resolution of jaundice. </P>
<P>Resection of tumor was possible in only 33/85. </P>
<P>Trial was terminated as analysis of available data showed that estimated sample size was inadequate.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lygidakis-1987">
<CHAR_METHODS>
<P>Randomised clinical trial. </P>
<P>Generation of allocation sequence: unclear. </P>
<P>Allocation concealment: unclear.</P>
<P>Double blinding: not performed. </P>
<P>Follow-up: no. </P>
<P>Intention to treat analysis: no.</P>
<P>Sample size calculation: no.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Country: The Netherlands. </P>
<P>Number of participants randomised: 38; 21 males and 17 females, mean age was 59 years. </P>
<P>Inclusion criteria: <BR/>obstructive jaundice secondary to carcinoma of pancreatic head, serum bilirubin &gt; 15 umol/litre, serum creatinine &lt; 2 gm/litre and resectable tumor. </P>
<P>Exclusion criteria: non-resectable tumor. </P>
<P>Following investigations were performed for diagnosing cancer in all the participants: <BR/>ultrasound of abdomen, computed tomography of abdomen and ERCP; selective hepatic arteriography and late phase splenoportography was performed in 28 cases.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Participants were divided into two groups: </P>
<P>Group 1 underwent ERCP with stenting (n = 19) prior to surgery; </P>
<P>Group 2 underwent ERCP without stenting (n = 19) prior to surgery.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pre-surgical outcome measures: <BR/>Decrease in bilirubin, coagulation profile improvement, complications. </P>
<P>Post-surgical outcome measures: <BR/>Mortality and complications.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Two patients died in group 2 (ERCP without stenting), one due to uncontrolled sepsis and the other due to rupture of aneurysm of hepatic artery. </P>
<P>None died in group 1 (ERCP with stenting). </P>
<P>Postsurgical complications were seen in 3 patients in group 1 and 14 in group 2. </P>
<P>This study favours endoscopic pre-surgical stenting in patients who are awaiting pancreatic head surgery.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ERCP = endoscopic retrograde cholangiopancreatiocgraphy.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aly-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is a meta-analysis of retrospective cohort studies. Patients undergoing both percutaneous and endoscopic biliary drainage were included.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heslin-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 39 patients had ERCP with biliary stenting and 35 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hodul-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 154 patients underwent ERCP with biliary stenting and 58 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jagannath-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 74 patients underwent ERCP with biliary drainage and 70 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marcus-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 22 patients underwent ERCP and biliary drainage and 30 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Martignoni-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 85 patients underwent ERCP and biliary stenting and 158 had direct surgical after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pisters-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective hospital database. 98 patients underwent ERCP and biliary drainage and 93 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sewnath-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 232 patients underwent ERCP and biliary stenting and 58 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sohn-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. Majority of patients underwent percutaneous biliary drainage and few had ERCP and biliary stenting.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Srivastava-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>This is an analysis of a retrospective data. 50 patients underwent ERCP and biliary stenting and 67 had direct surgery after ERCP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>ERCP = endoscopic retrograde cholangiopancreatiocgraphy</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Lai-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lygidakis-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Distribution of the different pancreatico-biliary malignancies in the two groups</TITLE>
<TABLE COLS="4" ROWS="7">
<TR>
<TH>
<P>Diagnosis</P>
</TH>
<TH>
<P>Stented group</P>
</TH>
<TH>
<P>No stented group</P>
</TH>
<TH>
<P>(OR; 95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Pancreatic carcinoma</P>
</TD>
<TD>
<P>31/62</P>
</TD>
<TD>
<P>39/63</P>
</TD>
<TD>
<P>0.59; 0.28 to 1.23</P>
</TD>
</TR>
<TR>
<TD>
<P>Periampullary carcinoma</P>
</TD>
<TD>
<P>08/62</P>
</TD>
<TD>
<P>06/63</P>
</TD>
<TD>
<P>1.43; 0.45 to 4.58</P>
</TD>
</TR>
<TR>
<TD>
<P>Gallbladder carcinoma</P>
</TD>
<TD>
<P>04/43</P>
</TD>
<TD>
<P>03/44</P>
</TD>
<TD>
<P>1.40; 0.29 to 6.67</P>
</TD>
</TR>
<TR>
<TD>
<P>Common bile duct carcinoma</P>
</TD>
<TD>
<P>14/43</P>
</TD>
<TD>
<P>12/44</P>
</TD>
<TD>
<P>1.29; 0.51 to 3.23</P>
</TD>
</TR>
<TR>
<TD>
<P>Intrahepatic cholangiocarcinoma</P>
</TD>
<TD>
<P>03/43</P>
</TD>
<TD>
<P>02/44</P>
</TD>
<TD>
<P>1.58; 0.25 to 9.93</P>
</TD>
</TR>
<TR>
<TD>
<P>Metastatic tumour</P>
</TD>
<TD>
<P>02/43</P>
</TD>
<TD>
<P>01/44</P>
</TD>
<TD>
<P>2.10; 0.18 to 24.02</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-11-11 10:58:40 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Post-hoc analysis of non-randomised studies</TITLE>
<TABLE COLS="6" ROWS="12">
<TR>
<TH>
<P>Outcome Measures</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>Patients</P>
</TH>
<TH>
<P>Stented group</P>
</TH>
<TH>
<P>No stented group</P>
</TH>
<TH>
<P>(OR; 95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Presurgical primary outcome (mortality)</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>01/878</P>
</TD>
<TD>
<P>00/635</P>
</TD>
<TD>
<P>2.77; 0.11 to 70.14</P>
</TD>
</TR>
<TR>
<TD>
<P>Post-surgical primary outcome (mortality)</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>25/878</P>
</TD>
<TD>
<P>25/635</P>
</TD>
<TD>
<P>0.91; 0.51 to 1.60</P>
</TD>
</TR>
<TR>
<TD>
<P>Post-surgical secondary outcomes</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Overall complications</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>312/878</P>
</TD>
<TD>
<P>208/635</P>
</TD>
<TD>
<P>1.02; 0.80 to 1.29</P>
</TD>
</TR>
<TR>
<TD>
<P>Wound infections</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>88/878</P>
</TD>
<TD>
<P>51/635</P>
</TD>
<TD>
<P>1.57; 1.06 to 2.32</P>
</TD>
</TR>
<TR>
<TD>
<P>Intrabdominal abscess</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>83/878</P>
</TD>
<TD>
<P>52/635</P>
</TD>
<TD>
<P>1.01; 0.68 to 1.50</P>
</TD>
</TR>
<TR>
<TD>
<P>Pancreatic fistula</P>
</TD>
<TD>
<P>05</P>
</TD>
<TD>
<P>958</P>
</TD>
<TD>
<P>29/518</P>
</TD>
<TD>
<P>20/440</P>
</TD>
<TD>
<P>1.00; 0.54 to 1.86</P>
</TD>
</TR>
<TR>
<TD>
<P>Haemorrhage</P>
</TD>
<TD>
<P>04</P>
</TD>
<TD>
<P>752</P>
</TD>
<TD>
<P>43/459</P>
</TD>
<TD>
<P>37/293</P>
</TD>
<TD>
<P>0.57; 0.34 to 0.96</P>
</TD>
</TR>
<TR>
<TD>
<P>Total outcomes</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Total mortality</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>26/878</P>
</TD>
<TD>
<P>25/635</P>
</TD>
<TD>
<P>0.94; 0.54 to 1.66</P>
</TD>
</TR>
<TR>
<TD>
<P>Total complications</P>
</TD>
<TD>
<P>08</P>
</TD>
<TD>
<P>1513</P>
</TD>
<TD>
<P>326/878</P>
</TD>
<TD>
<P>208/635</P>
</TD>
<TD>
<P>1.15; 0.90 to 1.46</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Pre-surgical primary outcome</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="79.25679758709778" CI_START="0.12449392253748356" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.1411764705882352" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="1.899036520454017" LOG_CI_START="-0.9048518491534518" LOG_EFFECT_SIZE="0.4970923356502825" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.4870857636131185" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="0.69495140065212">
<NAME>Mortality</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="79.25679758709778" CI_START="0.12449392253748351" EFFECT_SIZE="3.1411764705882352" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.899036520454017" LOG_CI_START="-0.904851849153452" LOG_EFFECT_SIZE="0.4970923356502825" ORDER="41798" O_E="0.0" SE="1.647017907778702" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.7126679885437324" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="41799" O_E="0.0" SE="0.0" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Pre-surgical secondary outcomes</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="761.8383350599474" CI_START="2.5119394327828926" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="43.74576271186441" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="2.881862822205365" LOG_CI_START="0.4000091635980848" LOG_EFFECT_SIZE="1.6409359929017246" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.009548838773402086" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="99.99999999999999" Z="2.5917526892602103">
<NAME>Overall complications</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="761.8383350599468" CI_START="2.511939432782894" EFFECT_SIZE="43.74576271186441" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="0" LOG_CI_END="2.8818628222053646" LOG_CI_START="0.4000091635980851" LOG_EFFECT_SIZE="1.6409359929017246" ORDER="41800" O_E="0.0" SE="1.457853124439662" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.1253357324384847" WEIGHT="99.99999999999999"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="41801" O_E="0.0" SE="0.0" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="493.0974443265071" CI_START="1.5781062713995277" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="27.895522388059703" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="2.6929327516332027" LOG_CI_START="0.19813624572280877" LOG_EFFECT_SIZE="1.4455344986780057" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.023129797858515058" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="2.271283889573328">
<NAME>Cholangitis</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="493.0974443265071" CI_START="1.5781062713995277" EFFECT_SIZE="27.895522388059703" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" LOG_CI_END="2.6929327516332027" LOG_CI_START="0.19813624572280877" LOG_EFFECT_SIZE="1.4455344986780057" ORDER="41802" O_E="0.0" SE="1.465455817013639" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.1475607516191118" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="41803" O_E="0.0" SE="0.0" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="79.25679758709778" CI_START="0.12449392253748356" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.1411764705882352" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="1.899036520454017" LOG_CI_START="-0.9048518491534518" LOG_EFFECT_SIZE="0.4970923356502825" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.4870857636131185" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="0.69495140065212">
<NAME>Bleeding</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="79.25679758709778" CI_START="0.12449392253748351" EFFECT_SIZE="3.1411764705882352" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.899036520454017" LOG_CI_START="-0.904851849153452" LOG_EFFECT_SIZE="0.4970923356502825" ORDER="41804" O_E="0.0" SE="1.647017907778702" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.7126679885437324" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="41805" O_E="0.0" SE="0.0" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2122.6640062550337" CI_START="7.089827385839893" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="122.67567567567568" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="3.326881255693297" LOG_CI_START="0.8506356616584112" LOG_EFFECT_SIZE="2.088758458675854" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="9.445891395829017E-4" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.0" Z="3.306530952559784">
<NAME>Number of patients with improvement of serum bilirubin</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="2122.6640062550337" CI_START="7.0898273858398895" EFFECT_SIZE="122.67567567567568" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="0" LOG_CI_END="3.326881255693297" LOG_CI_START="0.850635661658411" LOG_EFFECT_SIZE="2.088758458675854" ORDER="41806" O_E="0.0" SE="1.4545589195494708" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.1157416504409237" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-15.22337241586704" CI_START="-34.556627584132954" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-24.889999999999997" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="4.4976569093209614E-7" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" UNITS="" WEIGHT="100.00000000000001" Z="5.046589738832641">
<NAME>Serum bilirubin concentration before surgery</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<CONT_DATA CI_END="-15.22337241586704" CI_START="-34.556627584132954" EFFECT_SIZE="-24.889999999999997" ESTIMABLE="YES" MEAN_1="1.51" MEAN_2="26.4" ORDER="41807" SD_1="23.0" SD_2="23.0" SE="4.932043476503692" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Post-surgical primary outcome</NAME>
<DICH_OUTCOME CHI2="1.068794581772614" CI_END="2.235685225186608" CI_START="0.25366625508695617" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7530723063732494" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" I2="6.436651433853371" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.3494106567332674" LOG_CI_START="-0.5957373026019495" LOG_EFFECT_SIZE="-0.12316332293434108" METHOD="MH" NO="1" P_CHI2="0.30121828524489824" P_Q="0.0" P_Z="0.6094838672210263" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="0.5108103441018348">
<NAME>Moratlity (death in 30 days or maximum follow-up</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4744574124368217" CI_START="0.3035825134791902" EFFECT_SIZE="1.027027027027027" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5408869927582993" LOG_CI_START="-0.517723247658669" LOG_EFFECT_SIZE="0.011581872549815138" ORDER="41808" O_E="0.0" SE="0.6218328954261302" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.3866761498340445" WEIGHT="67.67647899399829"/>
<DICH_DATA CI_END="4.000986633127811" CI_START="0.008051925825875128" EFFECT_SIZE="0.1794871794871795" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6021671004495972" LOG_CI_START="-2.094100234474082" LOG_EFFECT_SIZE="-0.7459665670122424" ORDER="41809" O_E="0.0" SE="1.5838007792727304" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="2.508424908424908" WEIGHT="32.32352100600171"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Post-surgical secondary outcomes</NAME>
<DICH_OUTCOME CHI2="7.573403589659501" CI_END="0.9135113528725121" CI_START="0.22252431650695056" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.45086415849931505" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="32" I2="86.79589713975668" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.03928605098331181" LOG_CI_START="-0.6526225242436687" LOG_EFFECT_SIZE="-0.34595428761349023" METHOD="MH" NO="1" P_CHI2="0.0059236325383810184" P_Q="0.0" P_Z="0.027032569125575365" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="2.211047193770332">
<NAME>Overall complications</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.027408999173084" CI_START="0.36138718889122257" EFFECT_SIZE="0.8559670781893004" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" LOG_CI_END="0.3069413698898895" LOG_CI_START="-0.44202724716099084" LOG_EFFECT_SIZE="-0.06754293863555064" ORDER="41810" O_E="0.0" SE="0.43994787311013456" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.19355413105413105" WEIGHT="48.65633891874803"/>
<DICH_DATA CI_END="0.3320141479548122" CI_START="0.01350609782398429" EFFECT_SIZE="0.06696428571428571" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.4788434095255131" LOG_CI_START="-1.8694701090314503" LOG_EFFECT_SIZE="-1.1741567592784816" ORDER="41811" O_E="0.0" SE="0.8168610070029692" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.6672619047619048" WEIGHT="51.34366108125198"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0695328854880026" CI_START="0.020972258079167104" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.20833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.3158723318590311" LOG_CI_START="-1.6783548066102056" LOG_EFFECT_SIZE="-0.6812412373755872" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.1805467683444703" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="1.3390734327931724">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0695328854880026" CI_START="0.020972258079167104" EFFECT_SIZE="0.20833333333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3158723318590311" LOG_CI_START="-1.6783548066102056" LOG_EFFECT_SIZE="-0.6812412373755872" ORDER="41812" O_E="0.0" SE="1.171418892720372" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="1.3722222222222222" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.1419508433887833" CI_START="0.027941715060129393" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.4971993861107017" LOG_CI_START="-1.553746940444789" LOG_EFFECT_SIZE="-0.5282737771670437" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.31264965368834263" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="1.0096778875371801">
<NAME>Intra-abdominal abscess</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.1419508433887833" CI_START="0.027941715060129393" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4971993861107017" LOG_CI_START="-1.553746940444789" LOG_EFFECT_SIZE="-0.5282737771670437" ORDER="41813" O_E="0.0" SE="1.2047360245667467" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="1.4513888888888888" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.26436758434319" CI_START="0.012101023352951256" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3162393162393162" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.9172096255858116" LOG_CI_START="-1.9171779009441448" LOG_EFFECT_SIZE="-0.4999841376791667" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.4892684893817467" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="19" WEIGHT="99.99999999999999" Z="0.6914727739380104">
<NAME>Bleeding/haemorrhage</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.26436758434319" CI_START="0.012101023352951256" EFFECT_SIZE="0.3162393162393162" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9172096255858116" LOG_CI_START="-1.9171779009441448" LOG_EFFECT_SIZE="-0.4999841376791667" ORDER="41814" O_E="0.0" SE="1.6649332635282328" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="2.7720027720027716" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Overall mortality and complications</NAME>
<DICH_OUTCOME CHI2="1.3149342601766427" CI_END="3.894858903969811" CI_START="0.16942660503812335" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8123378122444572" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" I2="23.950570740649482" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.5904917294444658" LOG_CI_START="-0.771018391443295" LOG_EFFECT_SIZE="-0.09026333099941462" METHOD="MH" NO="1" P_CHI2="0.25150335226532183" P_Q="0.0" P_Z="0.7949583191653763" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.4522522561427762" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="99.99999999999999" Z="0.2598774334018405">
<NAME>Overall mortality</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.015210592450164" CI_START="0.37770039810200745" EFFECT_SIZE="1.2314814814814814" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.6037083283794669" LOG_CI_START="-0.4228525574191947" LOG_EFFECT_SIZE="0.09042788548013607" ORDER="41815" O_E="0.0" SE="0.6030069458764729" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.3636173767752715" WEIGHT="78.39641141316665"/>
<DICH_DATA CI_END="4.000986633127811" CI_START="0.008051925825875128" EFFECT_SIZE="0.1794871794871795" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6021671004495972" LOG_CI_START="-2.094100234474082" LOG_EFFECT_SIZE="-0.7459665670122424" ORDER="41816" O_E="0.0" SE="1.5838007792727304" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="2.508424908424908" WEIGHT="21.603588586833343"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.779572170937367" CI_END="23.67640891791612" CI_START="0.010595259801091916" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5008569692459223" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="32" I2="94.37556769991008" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="1.3743158321133369" LOG_CI_START="-1.9748883897037979" LOG_EFFECT_SIZE="-0.30028627879523057" METHOD="MH" NO="2" P_CHI2="2.4803427493891306E-5" P_Q="0.0" P_Z="0.7252456805426327" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="7.311995647718531" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="99.99999999999999" Z="0.35145679541206576">
<NAME>Overall complications</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.083382450379215" CI_START="1.374562094434844" EFFECT_SIZE="3.3333333333333335" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="18" LOG_CI_END="0.9075931271296122" LOG_CI_START="0.13816436343106317" LOG_EFFECT_SIZE="0.5228787452803376" ORDER="41817" O_E="0.0" SE="0.45196626453033445" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.20427350427350427" WEIGHT="51.49394212058234"/>
<DICH_DATA CI_END="0.3320141479548122" CI_START="0.01350609782398429" EFFECT_SIZE="0.06696428571428571" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" LOG_CI_END="-0.4788434095255131" LOG_CI_START="-1.8694701090314503" LOG_EFFECT_SIZE="-1.1741567592784816" ORDER="41818" O_E="0.0" SE="0.8168610070029692" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.6672619047619048" WEIGHT="48.50605787941765"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Diagnosis</NAME>
<DICH_OUTCOME CHI2="0.12775090902726238" CI_END="1.2339820901317022" CI_START="0.28058424634048346" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5884181631775639" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="39" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.09130885644485764" LOG_CI_START="-0.551936716484643" LOG_EFFECT_SIZE="-0.23031393001989267" METHOD="MH" NO="1" P_CHI2="0.7207755428269605" P_Q="0.0" P_Z="0.1604590577122329" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="1.4035293112739138">
<NAME>Pancreatic carcinoma</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2773194966145762" CI_START="0.23242835769255832" EFFECT_SIZE="0.5448717948717948" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" LOG_CI_END="0.10629954116454413" LOG_CI_START="-0.6337108864448819" LOG_EFFECT_SIZE="-0.26370567264016886" ORDER="41819" O_E="0.0" SE="0.43468578828847143" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.18895173453996983" WEIGHT="78.42047822204584"/>
<DICH_DATA CI_END="3.356532230891699" CI_START="0.16609735070620857" EFFECT_SIZE="0.7466666666666667" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="15" LOG_CI_END="0.525890821826676" LOG_CI_START="-0.7796372945976753" LOG_EFFECT_SIZE="-0.1268732363854996" ORDER="41820" O_E="0.0" SE="0.7668736780560655" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.5880952380952381" WEIGHT="21.579521777954163"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.01787735047531511" CI_END="4.575558744896123" CI_START="0.4468264583727699" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4298533872598584" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.6604441355627639" LOG_CI_START="-0.34986111849044466" LOG_EFFECT_SIZE="0.1552915085361596" METHOD="MH" NO="2" P_CHI2="0.8936349005029955" P_Q="0.0" P_Z="0.5468264727891207" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="62" TOTAL_2="63" WEIGHT="100.0" Z="0.602522381457867">
<NAME>Periampullary carcinoma</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.92544508011692" CI_START="0.24992581994829582" EFFECT_SIZE="1.575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9967499906497421" LOG_CI_START="-0.6021888743985034" LOG_EFFECT_SIZE="0.1972805581256193" ORDER="41821" O_E="0.0" SE="0.9392246042043709" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.8821428571428572" WEIGHT="38.42264914054601"/>
<DICH_DATA CI_END="6.0205656246064425" CI_START="0.2979265298859768" EFFECT_SIZE="1.3392857142857142" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7796372945976752" LOG_CI_START="-0.525890821826676" LOG_EFFECT_SIZE="0.1268732363854996" ORDER="41822" O_E="0.0" SE="0.7668736780560655" STUDY_ID="STD-Lygidakis-1987" TOTAL_1="19" TOTAL_2="19" VAR="0.5880952380952381" WEIGHT="61.57735085945399"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.669295890288627" CI_START="0.29460220076627885" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.4017094017094016" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="0.8240799857750725" LOG_CI_START="-0.530764013172" LOG_EFFECT_SIZE="0.1466579863015362" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.6713317369758866" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.00000000000001" Z="0.4243209866517019">
<NAME>Gallbladder carcinoma</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.669295890288627" CI_START="0.29460220076627885" EFFECT_SIZE="1.4017094017094016" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.8240799857750725" LOG_CI_START="-0.530764013172" LOG_EFFECT_SIZE="0.1466579863015362" ORDER="41823" O_E="0.0" SE="0.7958420715674676" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.6333646028767981" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.231441371941274" CI_START="0.5128628709681459" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2873563218390804" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="0.509396280922976" LOG_CI_START="-0.28999874081984983" LOG_EFFECT_SIZE="0.10969877005156306" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.5906316720321201" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.0" Z="0.537920884172267">
<NAME>Common bile duct carcinoma</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.231441371941274" CI_START="0.5128628709681459" EFFECT_SIZE="1.2873563218390804" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.509396280922976" LOG_CI_START="-0.28999874081984983" LOG_EFFECT_SIZE="0.10969877005156306" ORDER="41824" O_E="0.0" SE="0.46956859284091224" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.2204946633825944" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.925445080116916" CI_START="0.24992581994829588" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="0.9967499906497419" LOG_CI_START="-0.6021888743985034" LOG_EFFECT_SIZE="0.1972805581256193" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.6286348199798887" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.0" Z="0.4836492466702379">
<NAME>Intrahepatic cholangiocarcinoma</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.92544508011692" CI_START="0.24992581994829582" EFFECT_SIZE="1.575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9967499906497421" LOG_CI_START="-0.6021888743985034" LOG_EFFECT_SIZE="0.1972805581256193" ORDER="41825" O_E="0.0" SE="0.9392246042043709" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.8821428571428572" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="24.024091147896343" CI_START="0.18313958348373208" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="1.3806469669162547" LOG_CI_START="-0.7372177778685902" LOG_EFFECT_SIZE="0.3217145945238322" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.5515378320416455" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="44" WEIGHT="100.0" Z="0.5954573068184069">
<NAME>Metastatic tumour</NAME>
<GROUP_LABEL_1>Stenting</GROUP_LABEL_1>
<GROUP_LABEL_2>No stenting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours stenting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no stenting</GRAPH_LABEL_2>
<DICH_DATA CI_END="24.024091147896343" CI_START="0.18313958348373208" EFFECT_SIZE="2.097560975609756" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3806469669162547" LOG_CI_START="-0.7372177778685902" LOG_EFFECT_SIZE="0.3217145945238322" ORDER="41826" O_E="0.0" SE="1.2440442346861817" STUDY_ID="STD-Lai-1994" TOTAL_1="43" TOTAL_2="44" VAR="1.5476460578559275" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-11 10:59:02 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-11 10:59:02 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-11 10:58:16 +0100" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-11 10:59:02 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Time span</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Search strategy</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The Cochrane Hepato-Biliary Group Controlled Trials Register</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>October 2006.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(ERCP OR 'endoscopic retrograde cholangiopancreaticography' OR 'endoscopic retrograde cholangiopancreatography') AND (pancreaticobiliary OR pancreatobiliary OR (pancreat* AND biliary)) AND stricture*</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Issue 2 of 2006.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 MeSH descriptor Cholangiopancreatography, Endoscopic Retrograde explode all trees in MeSH products<BR/>#2 ERCP or endoscopic retrograde cholangiopancreat*graphy in All Fields in all products<BR/>#3 (#1 OR #2)<BR/>#4 pancreat*biliary and stricture* in All Fields in all products<BR/>#5 (#3 AND #4)<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MEDLINE (WinSPIRS 5.0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1950 to October 2006.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 explode "Cholangiopancreatography-Endoscopic-Retrograde"/ all subheadings<BR/>#2 ERCP or endoscopic retrograde cholangiopancreat*graphy<BR/>#3 #1 or #2<BR/>#4 pancreat*biliary and stricture*<BR/>#5 #3 and #4<BR/>#6 random* or blind* or placebo* or meta-analysis<BR/>#7 #5 and #6</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EMBASE (WinSPIRS 5.0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to October 2006.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 explode "endoscopic-retrograde-cholangiopancreatography"/ all subheadings<BR/>#2 ERCP or endoscopic retrograde cholangiopancreat*graphy<BR/>#3 #1 or #2<BR/>#4 pancreat*biliary and stricture*<BR/>#5 #3 and #4<BR/>#6 random* or blind* or placebo* or meta-analysis<BR/>#7 #5 and #6<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Science Citation Index EXPANDED (http://portal.isiknowledge.com/portal.cgi?DestApp=WOS&amp;Func=Frame)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1945 to October 2006.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 TS=(ERCP or endoscopic retrograde cholangiopancreat*graphy)<BR/>#2 TS=(pancreat*biliary and stricture*)<BR/>#3 #2 AND #1<BR/>#4 TS=(random* or blind* or placebo* or meta-analysis)<BR/>#5 #4 AND #3<BR/>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>